195,130 Shares in Crescent Capital BDC, Inc. (NASDAQ:CCAP) Purchased by Raymond James Financial Inc.

Raymond James Financial Inc. bought a new position in Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 195,130 shares of the company's stock, valued at approximately $3,750,000. Raymond James Financial Inc. owned about 0.53% of Crescent Capital BDC at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Franklin Resources Inc. raised its holdings in shares of Crescent Capital BDC by 35.2% during the third quarter. Franklin Resources Inc. now owns 256,279 shares of the company's stock valued at $4,726,000 after acquiring an additional 66,713 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Crescent Capital BDC during the 4th quarter valued at $661,000. Redhawk Wealth Advisors Inc. bought a new position in Crescent Capital BDC in the 4th quarter worth $659,000. Oppenheimer & Co. Inc. bought a new position in Crescent Capital BDC in the 4th quarter worth $261,000. Finally, Condor Capital Management lifted its position in shares of Crescent Capital BDC by 4.7% in the 4th quarter. Condor Capital Management now owns 284,055 shares of the company's stock worth $5,460,000 after purchasing an additional 12,852 shares during the period. Hedge funds and other institutional investors own 49.46% of the company's stock.

Crescent Capital BDC Stock Up 1.6 %

Shares of Crescent Capital BDC stock traded up $0.25 during trading on Friday, hitting $15.96. The company's stock had a trading volume of 19,390 shares, compared to its average volume of 142,647. Crescent Capital BDC, Inc. has a 52 week low of $13.54 and a 52 week high of $20.19. The company has a market capitalization of $591.51 million, a PE ratio of 8.02 and a beta of 0.56. The company has a fifty day simple moving average of $16.56 and a two-hundred day simple moving average of $18.26. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.32.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last released its earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The business had revenue of $46.40 million for the quarter, compared to analysts' expectations of $47.27 million. Equities research analysts predict that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current year.

Crescent Capital BDC Announces Dividend

The company also recently announced a dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 30th will be issued a $0.05 dividend. The ex-dividend date is Friday, May 30th. Crescent Capital BDC's dividend payout ratio (DPR) is presently 84.42%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on CCAP. Wells Fargo & Company decreased their price target on shares of Crescent Capital BDC from $18.00 to $16.00 and set an "equal weight" rating for the company in a research note on Monday. Keefe, Bruyette & Woods decreased their target price on Crescent Capital BDC from $20.00 to $18.50 and set an "outperform" rating for the company in a research report on Tuesday, April 8th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $18.50.

Crescent Capital BDC Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.